MedPath

SITAGLIPTIN

SITAGLIPTIN

Approved
DIN Number

02548569

Drug Class

Human

Market Date

Dec 17, 2024

Company
HC

sanis health inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02548569
AIG Number0152414003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BH01 SITAGLIPTIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:20.05
Health Canada Classification

ACTIVE INGREDIENTS (1)

SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE)Active
Strength: 50 MG
Monograph: SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.